Disclosure Information - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Disclosure Information

Description:

Disclosure Information Dan Varga, MD discloses that he has nothing to disclose. – PowerPoint PPT presentation

Number of Views:160
Avg rating:3.0/5.0
Slides: 31
Provided by: Melanie222
Category:

less

Transcript and Presenter's Notes

Title: Disclosure Information


1
Disclosure Information
  • Dan Varga, MD discloses that he has nothing to
    disclose.

2
The ABCs of Vascular Disease
  • What is it?

3
Agenda
  • Peripheral Vascular Disease (PVD) defined
  • What is PAD (Peripheral Artery Disease)?
  • PAD Risk Factors
  • Signs Symptoms of Advanced PAD
  • PVD Conditions
  • Symptomatic Asymptomatic PAD
  • CLI (Critical Limb Ischemia)
  • Amputation Impact
  • Vascular Screening Recommendations
  • Vascular Tests Diagnosis of PAD
  • Non-invasive
  • Invasive
  • The MultidisciplinaryTeam
  • PAD Treatment Options
  • Vascular Center Organization Chart
  • Conclusion

4
What is Peripheral Vascular Disease?
  • Peripheral Vascular Disease (PVD) refers to
    diseases of blood vessels outside the heart and
    brain. It's often a narrowing of vessels that
    carry blood to the legs, arms, stomach or
    kidneys. There are two types of these circulation
    disorders
  • Functional peripheral vascular diseases don't
    have an organic cause. They don't involve defects
    in blood vessels' structure. They're usually
    short-term effects related to "spasm" that may
    come and go. Raynaud's disease is an example. It
    can be triggered by cold temperatures, emotional
    stress, working with vibrating machinery or
    smoking.
  • Organic peripheral vascular diseases are caused
    by structural changes in the blood vessels, such
    as inflammation and tissue damage. Peripheral
    artery disease is an example. It's caused by
    fatty buildups in arteries that block normal
    blood flow.

PVD definition is from the American Heart
Association
5
Peripheral Artery Disease (PAD)
  • PAD is most commonly caused by atherosclerotic
    plaque build up in the arteries. The plaque
    causes obstruction to blood flow in the
    extremities of the body, such as the legs.
  • PAD affects 12-20 of Americans age 65 and older.
  • Only 25 of PVD patients are in treatment.
  • 14-18 million have PAD (in the US)
  • 3x greater risk for diabetics over the age of 50
  • 4x-5x higher risk of dying from a cardiovascular
    event

Period Change 28
Source Meditech Insights U.S. Markets for
Interventional Peripheral Vascular Products
6
PAD Risk Factors
  • NON-MODIFIABLE RISKS
  • Age. The risk of limb loss due to PAD increases
    with age. People 65 or older are two to three
    times more likely to have an amputation.
  • Gender. Men with PAD are twice as likely to
    undergo an amputation as women.
  • Race/ethnicity. Some racial and ethnic groups
    have a higher risk of amputation (i.e., African
    Americans, Latino Americans, and Native
    Americans). This is because they are at increased
    risk for diabetes and cardiovascular disease.
  • Family history of heart disease. A family history
    of cardiovascular disease is an indicator for
    risk at developing PAD.
  • MODIFIABLE RISKS
  • Cigarette smoking.  Smoking is a major risk
    factor for PAD. Smokers may have four times
    the risk of PAD than nonsmokers. 
  • Obesity. People with a Body Mass Index (BMI) of
    25 or higher are more likely to develop heart
    disease and stroke even if they have no other
    risk factors. 
  • Diabetes mellitus.  Having diabetes puts
    individuals at greater risk of developing PAD as
    well as other cardiovascular diseases. 
  • Physical inactivity.  Physical activity increases
    the distance that people with PAD can walk
    without pain and also helps decrease the risk of
    heart attack or stroke. Supervised exercise
    programs are one of the treatments for PAD
    patients. 
  • High blood cholesterol.  High cholesterol
    contributes to the build-up of plaque in the
    arteries, which can significantly reduce the
    blood's flow. This condition is known as
    atherosclerosis. Managing cholesterol levels is
    essential to prevent or treat PAD.
  • High blood pressure. When blood pressure remains
    high, the lining of the artery walls becomes
    damaged. Many PAD patients also have high blood
    pressure.
  • High levels of Homocysteine. This is an amino
    acid found in plasma (blood). Some recent studies
    show higher levels are associated with PAD.

7
Signs Symptoms of Advanced PAD
  • Pain in the toes or feet. This is called rest
    pain and occurs because the body is unable to
    deliver enough blood to the feet at rest. Rest
    pain usually worsens when the legs are elevated,
    and may be relieved by lowering the legs. When
    the legs are unable to get the nutrition needed
    for growth and repair, gangrene or death of the
    tissue can occur.
  • Decreased hair growth on the legs
  • Paleness of the leg or foot when elevated
  • Blue/red discoloration of the foot when hanging
    down
  • Absence of pulses in the foot
  • Numbness, tingling, or pain in the foot, toes or
    leg
  • Decreased ability to spread the toes and move the
    foot
  • Cool temperature of the foot and leg
  • A sore on the foot that does not heal
  • Fatigue in legs which may require may require
    patient to stop and rest while walking.
  • Slow or shuffled gait having difficulty keeping
    up with others.
  • Impotence may be a sign of iliac disease and may
    see some relief with sildenafil citrate.

8
Vascular Conditions
  • Abdominal Aneurysm 
  • Aortoiliac Disease 
  • Upper Extremity Disease 
  • Carotid Artery Disease 
  • Claudication
  • Deep Vein Thrombosis 
  • Diabetic Problems 
  • Hyperlipidemia
  • Lymphedema 
  • Mesenteric Ischemia
  • Peripheral Aneurysm 
  • Peripheral Arterial Disease 
  • Pulmonary Embolism 
  • Renovascular Conditions 
  • Thoracic Aneurysm 
  • Thoracic Outlet Syndrome 
  • Varicose Veins 
  • Venous Insufficiency 

9
Symptomatic Asymptomatic PAD
Hirsh AT et al. JAMA. 2001 289 1317-1324
10
Does Asymptomatic PAD Really Matter?
  • Coronary Artery Surgery Study (CASS) in patients
    with known CAD the presence of PAD increased
    Cardiovascular mortality by 25 during a 10-year
    follow-up (J AM Coll Cardiol 1994231091-5)
  • PAD, symptomatic or asymptomatic, is a powerful
    independent predictor of CAD and CVD (Vasc.
    Med. 3, 241, 1998)

PAD severity ABI Mortality Rate / CAD Death (10 year)
None WNL 11
Mild to Moderate 0.9 - 0.6 40
Moderate to Severe lt 0.6 60
11
Critical Limb Ischemia (CLI)
  • CLI affects 2 million Americans who are at risk
    for amputation of the toes, feet legs
  • 40 of amputees die within 2 years
  • CLI causes persistently recurring rest pain
    requiring regular analgesia
  • CLI is a non-healing ulceration or gangrene of
    the foot or toes. Threatened limb loss or tissue
    loss
  • Rutherford Becker Categories 4 6
  • 4 Ischemic rest pain
  • 5 minor tissue loss, e.g. non-healing ulcer,
    focal gangrene
  • 6 major tissue loss, i.e. above transmet level

12
CLI Vascular Compromise (Impact Mortality)
  • Often due to diffuse, multi-level arterial
    involvement
  • Frequently involves infra-popliteal arteries with
    sever diffuse disease and/or total occlusion
  • Diabetics often have entirely infra-popliteal
    disease

Mortality rates for CLI patients at Mortality rates for CLI patients at
One year 25.0
Two years 31.6
Three years 60.0
13
Amputation Impact
  • International Diabetes Federation estimates that
    somewhere in the world, a leg is lost to diabetes
    every 30 seconds
  • The risk of leg amputation is 15-40 times greater
    for a person with diabetes
  • Each year there are 150,000 lower extremity
    amputations with a 270 million price

Source American Cancer Society, American Heart
Association, Alzheimer's Disease Education /
Referral Center, American Diabetes Association,
SAGE Group.
14
Does Asymptomatic PAD Really Matter?
15
Vascular Screening Recommendations
  • ADA Consensus Panel recommends ABI Screening for
  • Patients over the age of 50 years who have
    diabetes
  • Patients with diabetes younger than 50 years of
    age who have other PAD risk factors (i.e.
    smoking, hypertension, hyperlipidemia, diabetes
    more than 10 years)
  • ABI should be repeated in 5 years if normal
  • If ABI is abnormal, then patient should be
    referred
  • TASC II recommends ABI Screening for
  • All patients who have exertional leg symptoms
  • All patients between the age of 50-69 and who
    have a cardiovascular risk factor
  • All patients age greater than 70 years regardless
    of risk factor status
  • All patients with a Framingham risk score of
    10-20

16
Vascular Tests Diagnosis of PAD
  • Non-invasive techniques
  • ABI (Ankle/Brachial Index)
  • Exercise Test
  • Segmental Pressures
  • Segmental Volume Plethysmography
  • Duplex Ultrasonography
  • CT Angiogram
  • MRA (Magnetic Resonance Arteriography)
  • Carotid Doppler identifies patients who are at
    risk for stroke
  • Vascular ultrasound
  • Invasive techniques
  • Peripheral Angiograms
  • CT Angiograms
  • MR Angiograms

17
PAD Diagnosic TestABI (Ankle-Brachial Index)
Medicare Reimbursement of CPT Code 93922 97 -
165 (depending on location)
  • Simple, reliable means for diagnosing PAD.  Blood
    pressure measurements are taken at the arms and
    ankles using a Doppler.
  • The ABI test is simple enough to be performed in
    any doctor's office.
  • Inexpensive equipment and reimbursable tests.
  • Please note Blood-flow waveform analysis must be
    included for Medicare reimbursement. CPT 93922
    provides coverage for a single-level lower
    extremity physiologic study. Test must be
    diagnosed as medically necessary (e.g. leg pain
    when walking).
  • Sample vendors that meet reimbursement criteria
  • LifeDop ABI (2,000)
  • PADnet (22,000 auto transmission)

18
Normal ABI Exceptions
  • Normal resting ABI does not exclude PAD in
    patients with symptoms of PAD
  • Exercise induced claudication
  • Patients with diabetes with arterial claudication
  • Toe pressures

19
PAD Diagnostic Test Segmental Pressures
  • Similar to the ABI plus 2 or 3 additional blood
    pressure cuffs. These additional cuffs are placed
    just below the knee and one large cuff or two
    narrow cuffs are placed above the knee and at the
    upper thigh. These cuffs are then inflated above
    your normal systolic blood pressure, and then
    slowly deflated.
  • Using the Doppler instrument, a significant drop
    in pressure between two adjacent cuffs indicates
    a narrowing of the artery or blockage along the
    arteries in this portion of your leg. This allows
    the physician to identify more precisely the
    location of such blockages in the arteries of
    your leg.

20
PAD Diagnostic TestDuplex Scanning
  • Duplex Scanning a combination of real-time and
    Doppler ultrasonography
  • Purpose to evaluate arterial and venous
    disorders noninvasively.
  • The most common application for the examination
    is to determine the presence of deep vein
    thrombosis (DVT) in the extremity, usually
    because of leg swelling.
  • The deep veins are examined every 1-2 cm and
    gentle pressure is applied with the scan head to
    demonstrate that the walls of the vein can be
    easily collapsed. When thrombus is present there
    is little if any compressibility. The flow
    patterns are also assessed with Doppler
    recording. The presence or absence of venous
    valve insufficiency is assessed with compression
    maneuvers of the extremity.
  • TYPES OF DUPLEX SCANS
  • Extracranial Cerebrovascular
  • Abdominal
  • Renal
  • Aortoiliac
  • Mesenteric Arterial
  • Venous Duplex Scan Upper and Lower Extremities

21
The Team
22
The Team
  • Podiatry
  • Care directly for patients with CLI
  • Wound Care Medication, Debridement, HBO, Skin
    Grafting, Limited Amputation
  • Identify Patients who may benefit from
    revascularizationfor claudication as well as for
    CLI
  • Serve as Gate Keeper/PCP as 70 of patients
    with PAD also have CAD , Carotid Disease, other
    vascular disease (AAA, RAS)

23
The Multidisciplinary Team
  • Interventional Cardiology
  • Committed to Endovascular Revascularization
  • Management of Dyslipidemia
  • Screening for CAD nuclear stress testing
  • Evaluation of carotid disease stenting vs. CEA
  • Interventional Radiology
  • Committed to Endovascular Revascularization
  • Experts in Vascular Imaging
  • Screening for Vascular Disease in other areas
  • Experts in Endovascular Therapy for other
    Vascular areas
  • Surgery
  • Committed to Endovascular Revascularization
  • Experts in Vascular Disease
  • Screening for Vascular Disease in other areas
  • Can offer both Open and Endovascular
    Revascularization
  • Experts in Vascular Imaging
  • MOST PATIENTS WITH PAD DIE FROM MI OR STROKE

24
PAD Treatment Options
  • Medical
  • Risk Factor Modification
  • Exercise Therapy
  • Drug Therapy
  • Endovascular Therapy
  • Peripheral Transluminal Therapy
  • Peripheral Stenting
  • Angioplasty
  • Laser
  • Cryoplasty
  • Atherectomy
  • Thrombolic Therapy (adjunctive)
  • Surgery
  • Bypass Grafts
  • Amputation
  • Endarterectomy

25
AAA Screening
  • Medicare now pays for this!
  • Class 1 Indication Current or prior
  • Smoking history, male, age 65-75
  • Ultrasound, CT or MRA all acceptable, but
  • cost argues for ultra sound

26
Medical Care of the PAD Patient
  • Remember You are treating a systemic disease

27
Medical Care of the PAD Patient
  • Most PAD patients will die of cardiovascular
    disease distant from the affected limb.
  • Five year MI risk of mild claudicants exceeds
    that of a MI survivor!
  • CLI patients have an exceptionally poor
    prognosisaverage survival less than one year in
    some series.

28
Medical Care of the PAD Patient
  • Antiplatelet agents
  • --ASA or Clopidogrel both in high risk patients
    only
  • Lipid lowering agents
  • --PAD is a CAD risk equivalent LDL target is
    ,100
  • --Statins are the preferred agent
  • Blood Pressure targets are also secondary
    prevention targets

29
Vascular Center Organizational Chart
30
Thank you.
Write a Comment
User Comments (0)
About PowerShow.com